PIPELINE
Developing innovative therapeutics for combating serious diseases
INVENT Pharmaceuticals is developing a portfolio of small molecule therapeutics targeting cardiorenal, cardiopulmonary, fibrotic, neuroendocrine and neurological diseases and psychiatric disorders.
Our Commitment
We are committed to advancing transformative therapeutics through the integration of precision science, cutting-edge technology, and deep therapeutic expertise.
© 2026 INVENT Pharmaceuticals. All rights reserved.